Abstract
Targeted drug delivery systems using nanocarriers have emerged as a promising strategy for enhancing the therapeutic efficacy and minimizing side effects of conventional treatments. This article discusses the latest advancements in the design of nanocarriers, focusing on their potential to deliver drugs precisely to the desired sites, thus improving the pharmacokinetics and therapeutic outcomes. The paper reviews various strategies, including ligand-receptor mediated targeting, stimuli-responsive nanocarriers, and the use of multifunctional nanoparticles. Furthermore, challenges in clinical translation and future directions in nanocarrier design are also discussed.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Dr. Emily Stone (Author)